PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Changes in asthma treatment improve wait time and patient care in Emergency

2012-04-04
(Press-News.org) OTTAWA, Canada -- Dr. Roger Zemek, Director of Emergency Research at the CHEO Research Institute and ED physician, and assistant professor in the Faculty of Medicine at the University of Ottawa, has overseen the creation and implementation of a Medical Directive that now empowers nurses to administer an oral steroid treatment, which has reduced wait time and improved patient care. This research is published today in Pediatrics.

Asthma is the most common chronic illness in children requiring a visit to Emergency. Every year, the Children's Hospital of Eastern Ontario (CHEO) sees more than 2,500 patients with asthma. Two thirds of these asthma patients present with more than mild symptoms, meaning they have respiratory distress requiring increased levels of care, which may include requiring overnight admission to the hospital.

Traditionally, for patients presenting with asthma arriving at the Emergency Department (ED), the triage nursing staff would administer a relief medicine in a puffer or mask, to open the airways and ease breathing. Now, there is one more treatment option available on arrival in Emergency for children with moderate to severe asthma. This option empowers nurses to administer an oral steroid treatment.

Oral steroids are routinely used in the treatment of moderate to severe asthma. "Before this Medical Directive for asthma treatment was initiated at CHEO, patients and their families would have to wait to see a physician before the oral steroid could be ordered and given," said Debby Voskamp, nursing educator in CHEO's Emergency Department. "Because it often takes a few hours to see improvement in patients who receive oral steroid medication, it made sense to give this treatment early in the Emergency visit. We are pleased to be part of putting this research into practice and making positive change happen." The immediate impact on front line care has caught the eye of physicians, staff and hospital administrators alike.

CHEO's Emergency Department has 12 other Medical Directives in place now, but today's announcement is the first relating to administering steroids to treat asthma. This Medical Directive clearly documents the type of care children with asthma should receive, depending on how they score on a standardized assessment to determine the severity of their asthma performed by triage nurses when they arrive at the hospital. The assessment evaluates multiple factors including muscle exertion, wheezing and oxygen saturation.

"A critical part of this research included getting unanimous support from Pharmacy, Respirology, nursing educators and all of the Emergency physicians before we could implement the Medical Directive," said Dr. Roger Zemek. "We worked closely with the CHEO Medical Directive Committee and Medical Advisory Committee to prove that this Medical Directive is a safe, effective and appropriate intervention. We wanted to take asthma care to the next level, by offering rescue treatments over breathing treatments. Our strategy is something that other hospitals can model."

The front line impact of this research put into practice is significant. A review of more than 600 patients' medical records revealed that admission rates of patients with moderate to severe asthma dropped by one third, and patients who received oral steroids upon arrival at the emergency department tended to leave the hospital on average 45 minutes sooner. In fact, there was a direct correlation between how soon an oral steroid is administered and how soon patients gets better, as measured by their before and after scores on the standardized assessment.

### This research was funded by the Ontario Academic Health Science Centre Innovation Fund.

About the CHEO Research Institute Established in 1984, the CHEO Research Institute coordinates the research activities of the Children's Hospital of Eastern Ontario (CHEO) and is one of the institutes associated with the University of Ottawa Teaching Hospitals. The Research Institute brings together health professionals from within CHEO to share their efforts in solving pediatric health problems. It also promotes collaborative research outside the hospital with partners from the immediate community, industry and the international scientific world. For more information, please visit www.cheori.org.

About the University of Ottawa The University of Ottawa is committed to research excellence and encourages an interdisciplinary approach to knowledge creation, which attracts the best academic talent from across Canada and around the world.


ELSE PRESS RELEASES FROM THIS DATE:

New drug prevents spread of human prostate cancer cells

2012-04-04
CHICAGO --- A new drug developed by Northwestern Medicine scientists prevented human prostate cancer cells from spreading to other tissues without any toxic effects to normal cells or tissues. The drug turns off the "go" switch in the cancer cells and immobilizes them. Prostate cancer is the second-leading cause of cancer death in North American males. Death is mainly caused by metastasis, prostate cancer cells moving out of prostate tissue and spreading to other organs. "This is an extremely promising new therapeutic that locks down aggressive prostate cancer cells ...

Gladstone scientists find increased ApoE protein levels may promote Alzheimer's disease

2012-04-04
SAN FRANCISCO, CA—April 3, 2012—Scientists at the Gladstone Institutes have enhanced our understanding of how a protein linked to Alzheimer's disease keeps young brains healthy, but can damage them later in life—suggesting new research avenues for treating this devastating disease. In the Journal of Neuroscience, available online today, researchers in the laboratory of Yadong Huang, MD, PhD, have uncovered the distinct roles that the apoE protein plays in young vs. aging brains. These findings, which could inform the future of Alzheimer's drug development, come at a time ...

Pollen can protect mahogany from extinction

2012-04-04
New research from the University of Adelaide could help protect one of the world's most globally threatened tree species - the big leaf mahogany - from extinction. Big leaf mahogany (Swietenia macrophylla) is the most prized mahogany timber around the world. It is at risk of extinction in its native habitats because of the timber trade, particularly in Central and South America. To better understand how such a threatened species can be brought back from the brink of extinction, scientists from the University of Adelaide's Environment Institute have studied the important ...

Stomata development in plants unraveled -- a valuable discovery for environmental research

2012-04-04
Plants breathe through stomata Plant leaves are protected from drying out by an airtight wax layer. They breathe and release water through microscopic pores called stomata. Every year 40% of atmospheric CO2 and twice the volume of water found in our atmosphere pass through these pores. This means that stomata are not only important for plant development but also for our climate! It's no surprise then that these pores appear to be strictly regulated by plants. Stomata react extremely fast to internal plant signals and changes in the environment. When rain is scarce, ...

A study confirms that long commercials evoke stronger emotions

A study confirms that long commercials evoke stronger emotions
2012-04-04
What effect does a TV advert have on a viewer? How does it bring about a change in their knowledge, emotions or intentions? These questions have existed alongside advertising ever since it began. Through a psycho-physiological study developed jointly by El Bureau de la Comunicación, the Tecnalia Centre for Applied Research, and the UPV/EHU, it has been possible to measure the emotional response of a person to a series of television adverts. The aim of the study, carried out for the first time entirely in the Basque Autonomous Community (region), was to shed some light ...

Viral replication impedes the efficacy of a targeted therapy against virus-induced lymphomas

2012-04-04
Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi's sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis. Researchers at the University of Helsinki discovered that spontaneous induction of KSHV lytic replication in tumors drastically attenuated the p53-dependent apoptotic response not only to a targeted therapy (Nutlin-3) but also to genotoxic anti-cancer agents. The findings by the research groups of Päivi Ojala (Institute of ...

Serious complications after esophageal surgery cause lasting health problems in long-term survivors

2012-04-04
Oesophageal cancer is a very serious form of cancer that, if not fatal, requires extensive surgery. A new study from Karolinska Institutet in Sweden shows that when serious complications arise after surgery for oesophageal cancer, many patients suffer other health problems, such as breathlessness, fatigue, insomnia and eating problems, for five years afterwards. "Patients who suffer serious post-operative complications after surgery for oesophageal cancer need very close, long-term monitoring so that any problems that arise can be identified and targeted quickly," says ...

Is bioenergy expansion harmful to wildlife?

2012-04-04
Despite the predicted environmental benefits of biofuels, converting land to grow bioenergy crops may harm native wildlife. Researchers at the Helmholtz Centre for Environmental Research in Leipzig have developed a way to study the effects of increased energy crop cultivation on farmland bird populations. "The Skylark is an indicator species for agricultural areas because it occupies many habitats of the wider countryside around the globe, breeds on the ground within fields and feeds mostly on insects" notes lead researcher, Jan Engel. "Improving the habitat suitability ...

New immune defense enzyme discovered

New immune defense enzyme discovered
2012-04-04
Neutrophil granulocytes comprise important defences for the immune system. When pathogenic bacteria penetrate the body, they are the first on the scene to mobilise other immune cells via signal molecules, thereby containing the risk. To this end, they release serine proteases – enzymes that cut up other proteins to activate signal molecules. Scientists at the Max Planck Institute of Neurobiology in Martinsried have now discovered a new serine protease: neutrophil serine protease 4, or NSP4. This enzyme could provide a new target for the treatment of diseases that involve ...

Are we really a nation of animal lovers?

2012-04-04
A new study has estimated that over 260,000 cats and dogs entered the care of UK rescue organisations during 2009, the first full year since the onset of the UK recession. The aim of the research was to estimate the number of cats and dogs, currently being cared for by UK welfare organisations, the proportion of time that these organisations were full to capacity and the number entering these organisations during a 12-month period. The University of Bristol study by Dr Corinna Clark and colleagues in the School of Veterinary Sciences is published in the Veterinary ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Changes in asthma treatment improve wait time and patient care in Emergency